Bone Marrow TransplantationAnemia, AplasticTransplantation, HomologousHematopoietic Stem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningBone MarrowTransplantation, AutologousBone Marrow CellsWhole-Body IrradiationHematologic NeoplasmsTransplantation ChimeraTissue DonorsLiver TransplantationStem Cell TransplantationHistocompatibility TestingLeukemiaGraft SurvivalHistocompatibilityMyeloablative AgonistsAnemiaHematopoietic Stem CellsBusulfanTreatment OutcomeImmunosuppressive AgentsAntilymphocyte SerumPeripheral Blood Stem Cell TransplantationUnrelated DonorsKidney TransplantationRecurrenceLeukemia, Myeloid, AcuteBone and BonesHematopoiesisRetrospective StudiesGraft RejectionMyelodysplastic SyndromesCord Blood Stem Cell TransplantationCyclophosphamideHLA AntigensRemission InductionSurvival AnalysisGraft vs Tumor EffectCyclosporineTime FactorsCombined Modality TherapyImmunosuppressionTransplantation, IsogeneicTransplantation ImmunologyHematologic DiseasesVidarabineLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Leukemia EffectSurvival RatePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow PurgingHeart TransplantationAcute DiseaseBone Marrow DiseasesSiblingsChimerismDisease-Free SurvivalFanconi AnemiaHepatic Veno-Occlusive DiseaseCell TransplantationPancytopeniaMice, Inbred C57BLLymphoma, Non-HodgkinLung TransplantationFollow-Up StudiesT-LymphocytesLeukemia, MyeloidLymphocyte DepletionLymphocyte TransfusionTransplantationMultiple MyelomaGraft vs Host ReactionSevere Combined ImmunodeficiencyRadiation ChimeraOrgan TransplantationColony-Forming Units AssayLiving DonorsCytomegalovirus InfectionsDonor SelectionBone Marrow ExaminationAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34PrognosisGranulocyte Colony-Stimulating FactorCell DifferentiationRisk FactorsInfectionHemoglobinuria, ParoxysmalIslets of Langerhans TransplantationFlow CytometryMinor Histocompatibility AntigensLeukocyte TransfusionMelphalanSalvage TherapyLymphomaHodgkin Disease